Home » Lupin Gets USFDA Nod for Additional Strengths of Cholesterol Drug
Lupin Gets USFDA Nod for Additional Strengths of Cholesterol Drug
Lupin has gotten approval from the FDA for its sNDA to market new strengths of the cholesterol drug Antara.
The Economic Times
The Economic Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May